IGF2 and colorectal carcinoma: In contrast, the sensitivity of IGF2 was 83%, and the specificities of CACNA1G and SOCS1 were 87 and 86%, respectively, in our CRC population, while the sensitivity of CDKN2A was 87% among American CRCs [32].